Insights from 2025 ASCO® GI Annual Meeting
Video Player is loading.
10 seconds
Playback speed
ASCO® GI 2025 Insights: Ph2 INNOVATION Trial - Outcomes of Perioperative Chemo + Trastuzumab +/- Pertuzumab for 1L HER2+ Gastric/GEJ Cancer
Comments 0
Login to view comments.
Click here to Login
